Adalimumab in the treatment of pediatric Behçet's disease: case-based review.

Poddighe, Dimitri; Mukusheva, Zaure; Dauyey, Kaisar; Assylbekova, Maikesh

Poddighe, Dimitri; Mukusheva, Zaure; Dauyey, Kaisar; Assylbekova, Maikesh.

Afiliação

Poddighe D; Department of Medicine, School of Medicine, Nazarbayev University, Kerei-Zhanibek Str. 5/1, Astana, 010000, Kazakhstan. dimitri.poddighe@nu.edu.kz.
Mukusheva Z; Department of Pediatric Rheumatology, National Research Center of Mother and Child Health, University Medical Center, Astana, Kazakhstan.
Dauyey K; Department of Medicine, School of Medicine, Nazarbayev University, Kerei-Zhanibek Str. 5/1, Astana, 010000, Kazakhstan.
Assylbekova M; Department of Pediatric Rheumatology, National Research Center of Mother and Child Health, University Medical Center, Astana, Kazakhstan.

Rheumatol Int ; 39(6): 1107-1112, 2019 Jun.

Article em En | MEDLINE | ID: mdl-30976833

Assuntos

Adalimumab/uso terapêutico; Síndrome de Behçet/tratamento farmacológico; Inibidores do Fator de Necrose Tumoral/uso terapêutico; Criança; Colchicina/uso terapêutico; Humanos; Masculino; Moduladores de Tubulina/uso terapêutico

Palavras-chave

Adalimumab; Behçet's disease; Pediatric rheumatology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Adalimumab / Inibidores do Fator de Necrose Tumoral Limite: Child / Humans / Male Idioma: En Revista: Rheumatol Int Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Cazaquistão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google